New combo drug aims to ease arthritis pain without lifelong meds
Disease control
Terminated
This study tested a new drug called IHL-675A in people with rheumatoid arthritis to see if it safely reduces pain and improves daily function. About 20 volunteers took either IHL-675A, CBD, hydroxychloroquine, or a placebo twice daily for 24 weeks. The study was stopped early, so…
Phase: PHASE2 • Sponsor: Incannex Healthcare Ltd • Aim: Disease control
Last updated May 17, 2026 09:18 UTC